Piramal Pharma Solutions Expands its Aurora, Canada Facility

Piramal Enterprises Limited’s Pharma Solutions business announced plans to expand its Aurora facility in Canada with the addition of a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients (APIs). A total investment of ~CAD$25 million will be infused towards this expansion.

Known for its world-class lab services and production plants, the Piramal Pharma Solutions’ (PPS) Aurora facility will enhance its offerings to customers with this new addition that features ~10,500 sq. ft. of new manufacturing space. The additional capacity will cater to increasing customer demand as well as support the facility’s ability to provide APIs and HPAPIs down to an Occupational Exposure Limit (OEL) of 1mcg/m3. It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions’ Aurora facility.

“We are delighted to announce the capacity expansion at our Aurora facility in Canada,” Peter DeYoung, CEO, Piramal Pharma Solutions said. “This additional capacity will help us to strengthen our presence in Canada as well as service other geographies such as North America and Europe, whilst enabling us to support our customer’s API requirements and market demand for integrated solutions. As a Patient Centric organization, Piramal Pharma Solutions is committed to serving the patient community and reducing the burden of disease.”

This expansion will include two new reactor suites as well as a dedicated filter dryer room and a portable filter dryer. The expansion is expected to be completed and running by April 30, 2021.

  • <<
  • >>

Join the Discussion